The Alzheimer’s disease drug candidate J147 decreases blood plasma fatty acid levels via modulation of AMPK/ACC1 signaling in the liver

Title
The Alzheimer’s disease drug candidate J147 decreases blood plasma fatty acid levels via modulation of AMPK/ACC1 signaling in the liver
Authors
Keywords
Dementia, Aging, Blood biomarkers, Liver, Lipidomics, Drug discovery
Journal
BIOMEDICINE & PHARMACOTHERAPY
Volume 147, Issue -, Pages 112648
Publisher
Elsevier BV
Online
2022-01-18
DOI
10.1016/j.biopha.2022.112648

Ask authors/readers for more resources

Reprint

Contact the author

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now